Steven Zelenkofske's Net Worth

$1.79 Million

Estimate Recalculated Apr 10, 2024 04:32PM EST

Who is Steven Zelenkofske?

Steven Zelenkofske has an estimated net worth of $1.79 Million. This is based on reported shares across multiple companies, which include uniQure N.V., Cadrenal Therapeutics, Inc., Regado Biosciences Inc, and ACHILLION PHARMACEUTICALS INC.

SEC CIK

Steven Zelenkofske's CIK is 0001578333

Past Insider Trading and Trends

2018 was Steven Zelenkofske's most active year for acquiring shares with 3 total transactions. Steven Zelenkofske's most active month to acquire stocks was the month of December. 2020 was Steven Zelenkofske's most active year for disposing of shares, totalling 2 transactions. Steven Zelenkofske's most active month to dispose stocks was the month of December. 2018 saw Steven Zelenkofske paying a total of $0.00 for 530,751 shares, this is the most they've acquired in one year. In 2018 Steven Zelenkofske cashed out on 23,929 shares for a total of $888,723.06, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

uniQure N.V. (QURE) Snapshot price: $5.675

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-13.05%
-23.93K
$37.14
-$888,723.06
159.46K
Jun 6
Form 4
+4.79%
8.39K
—
—
183.39K
Jan 26
Form 4
∞
175K
—
—
175K
Jun 5
Form 3
—
0
—
—
0
No matching records found

Cadrenal Therapeutics, Inc. (CVKD) Snapshot price: $1.34

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 18
Form 3
—
0
—
—
0
No matching records found

Regado Biosciences Inc No price found

SVP & Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

ACHILLION PHARMACEUTICALS INC No price found

EVP, Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 28
Form 4
—
0
—
—
0
Jan 23
Form 4
—
0
—
—
0
Aug 20
Form 3
—
0
—
—
0
No matching records found